Program Type
Disease
Project Status

Displaying 101 - 125 of 191

Biomarkers Consortium – CSC Scientific Symposium
The Problem cancer research is a large and diverse field, making it difficult to coordinate efforts across its many subfields, which are fo...
Biomarkers Consortium – ctDNA Quality Control Materials Project
The Problem Tumor DNA circulating in bodily fluids offers researchers a valuable tool to study, and thus to treat, cancer. Yet the wide var...
Biomarkers Consortium – Longitudinal Proteomic Changes in CSF from ADNI: Towards Better Defining the Trajectory of Prodromal and Early Alzheimer’s Disease
The Problem Alzheimer’s disease (AD) Researchers lack the tools needed to diagnose pre-symptomatic and early disease, and to predict how/...
Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML)
The Problem Detection of measurable residual disease (MRD) is a strong predictor of relapse in acute and chronic leukemia, but its integrat...
Biomarkers Consortium – Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD)
The Problem The earliest stages of FTD are hard to detect until the disease has progressed and damage is more permanent. Experts believe th...
Biomarkers Consortium – Sarcopenia as a Valid Biomarker for Identifying Individuals at Risk of Disability
The Problem Compared to younger adults, older adults are at increased risk for developing physical disabilities and limited mobility, yet R...
Biomarkers Consortium – Treatments Against RA and Effect on FDG PET-CT (TARGET Biomarker Study)
The Problem Rheumatoid arthritis (RA) is currently difficult to treat and people with RA are at increased risk for developing cardiovascula...
Biomarkers Consortium – Vol-PACT Phase II: Advanced metrics and modeling with Volumetric CT for Precision Analysis of Clinical Trial results
The Problem The cancer research field lacks well-tested biomarkers to measure disease progression and to predict how patients respond to tr...
Cancer Research Fund
The Cancer Research Fund enables individuals to support cancer research at the National Cancer Institute (NCI). Goals Enable individua...
CarMollNat Muscular Dystrophy Fund
"In memorium for my parents, Molly Harris and Nathan Harris, and my brother, Merton Harris- They were so much to so many.” - Carol-Ann Ha...
Centralized Envelope Comparative Immunogenicity Study
Overview This project completed in June 2015. The Centralized Envelope Comparative Immunogenicity Study is an HIV/AIDS vaccine development p...
Charles A. Sanders, M.D., Scientific Symposium
Overview This program completed in October 2016. Under Dr. Charles A. Sanders’ visionary leadership, the FNIH has influenced the course ...
Clayton-Dedonder Mentorship Fellows Program
Overview The goal of the program is to strengthen mentorship activities and resources within the Fogarty HIV/AIDS training programs at exis...
Clinical Center Drug Donations
Overview The Clinical Center In-Kind Drug Donation Program provides pharmaceuticals that are donated through the public-private partnership...
Cognitive Aging Summit III
Overview This program completed in March 2017. Held in 2017, Cognitive Aging Summit III brought together more than 300 experts in a ...
Combining Epitope-Based Vaccine Design with Informatics-Based Evaluation to Obtain a Universal Influenza Vaccine
The Problem Every year, an estimated 291,000 to 646,000 people worldwide die from seasonal influenza-related respiratory illnesses. Current...
Comprehensive Cellular Vaccine Immune Monitoring Consortium
The Problem The development of a safe and broadly effective vaccine against HIV/AIDS has been elusive and, despite decades of effort, eve...
Biomarkers Consortium – In Silico Modeling of Biomarkers of Atherosclerosis: Estimating Risk Reduction and Residual Risk from Statin Therapy
Overview This project was completed in December 2018.  The Biomarkers Consortium’s In Silico Modeling of Biomarkers of Atherosclerosi...
Biomarkers Consortium – Inflammatory Markers for Early Detection and Subtyping of Neurodegenerative and Mood Disorders
The Problem Neurodegenerative and psychiatric conditions such as Alzheimer’s disease and Major Depressive Disorder present very differentl...
Biomarkers Consortium – Minimal Residual Disease (MRD) Detection in Adult Acute Lymphoblastic Leukemia (ALL)
Goals Evaluate existing data to determine the utility of MRD for predicting event-free survival (EFS) in pediatric and adult ALL. Standa...
Biomarkers Consortium – Mucosal Healing in UC: Definition, Treatment Target and Clinical Endpoints
The Problem Mucosal healing is an important outcome in clinical trials of drugs to treat ulcerative colitis, yet Researchers lack a standar...
Biomarkers Consortium – Neuroscience Symposium
Overview The Neuroscience Steering Committee, led by the FNIH and its co-chairs Dr. Linda Brady, Dr. Hartmuth Kolb, and the emeritus co-cha...
Biomarkers Consortium – NiP-Metastatic Prostate Cancer
Overview Metastatic castration-resistant prostate cancer (mCRPC) is the second leading cause of cancer death of American men. Over 80% of t...

Diseases

Partner With Us